What is the OncoNext Plus study?
OncoNext Plus is an enhanced genetic test that not only includes the core genes analyzed in OncoNext. It also adds analysis of additional genes associated with rare hereditary syndromes and specific genetic variants. This test provides an even more detailed insight into an individual's genetic risk. It also includes genes associated with rare forms of cancer and other hereditary diseases.
Why should we get tested with OncoNext Plus?
It is suitable for people who want a more detailed genetic analysis, including rare hereditary forms of cancer and other diseases. The study provides more complete information about genetic risk and preventive measures. This is especially important for individuals with a complex family history of cancer or other hereditary diseases. The test offers the opportunity for personalized prevention and treatment based on the individual's unique genetic profile.
What do we offer?
OncoNext Plus includes the same detailed analysis as OncoNext, but expanded with additional genes and genetic mutations that can be associated with various types of cancer and other hereditary diseases. The test also includes an analysis of genetic variants that may not be directly related to cancer but influence disease risk and the body's response to certain therapies.
Who should be tested with this test?
OncoNext Plus is recommended for individuals with a particularly complex family history of cancer, as well as for those who have developed several different forms of cancer or cancer at an early age. This test is also useful for people who desire a broader and more detailed analysis of their genetic predisposition to diseases.
What information does the test provide?
It provides an even deeper genetic analysis, including information on rare inherited syndromes and other genetic risk factors. This helps doctors and patients better understand individual genetic risk and take appropriate preventive and therapeutic measures, including early detection and targeted treatment of specific types of cancer and other genetically predisposed diseases.
How does OncoNext Plus differ from OncoNext?
While OncoNext primarily focuses on core genes associated with hereditary cancer syndromes, OncoNext Plus includes additional genes and mutations that cover a broader spectrum of diseases. This makes OncoNext Plus an ideal choice for individuals seeking the most detailed information possible about their genetic health and potential risks. With the added genes, the test offers a wider analysis and a better opportunity for early intervention and personalized medicine.
For more information and details regarding the test, you can call tel. ☎️ 0878 500 730
